The non-anticoagulation costs of atrial fibrillation management: Findings from an observational study in NHS Primary Care

Drugs in Context

Volumn , Issue , 2014, Pages

  Kassianos, George ^a   Arden, Chris ^b   Hogan, Simon ^c   Baldock, Laura ^d   Fuat, Ahmet ^e  

^a Ringmead Medical Practice   (United Kingdom)

^b Park Surgery   (United Kingdom)

^c Sanofi   (United Kingdom)

^d PH ASSOCIATES   (United Kingdom)

^e Carmel Medical Practice   (United Kingdom)

Author keywords

Atrial fibrillation; Health care costs; Observational study; Primary health care; Resource use

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; ATENOLOL; ATENOLOL PLUS CHLORTALIDONE; BISOPROLOL; CARVEDILOL; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; FLECAINIDE; LABETALOL; LERCANIDIPINE; METOPROLOL; NEBIVOLOL; NIFEDIPINE; PROPAFENONE; PROPRANOLOL; SOTALOL; VERAPAMIL;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CLINICAL PRACTICE; DISEASE DURATION; DRUG COST; DRUG SAFETY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HOSPITAL COST; HUMAN; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; THYROID FUNCTION TEST; TREATMENT DURATION; UNITED KINGDOM;

EID: 84899741997     PISSN: 17451981     EISSN: 17404398     Source Type: Journal    
DOI: 10.7573/dic.212254     Document Type: Article

References (21)

1. The Office of Health Economics. Estimating the direct costs of atrial fibrillation to the NHS in the constituent countries of the UK and at SHA level in England, 2008. London: The Office of Health Economics; 2009.
2. Kerr M. Atrial Fibrillation Cost Benefit Analysis. NHS Improvement 2008:1-17.
3. Go A, Hylek E, Phillips K, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. http://dx.doi.org/10.1001/jama.285.18.2370 (Pubitemid 32424106)
4. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66,547 patients hospitalized between 1986 and 1995. Circulation 2000;102:1126-31. http://dx.doi.org/10.1161/01.CIR.102.10.1126
5. Capewell S, MacIntyre K, Stewart S, et al. Age, sex and social trends in out-of-hospital cardiac deaths in Scotland 1986-1995: a retrospective cohort study. Lancet 2001;358(9289):1213-7. http://dx.doi.org/10.1016/S0140-6736(01) 06343-7 (Pubitemid 33010844)
6. Rosamond W, Chambless L, Folsom A, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7. http://dx.doi.org/10.1056/NEJM199809243391301 (Pubitemid 28446843)
7. Le Heuzey J, Paziaud O, Piot O, et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J 2004;147:121-6. http://dx.doi.org/10.1016/S0002-8703(03)00524-6 (Pubitemid 38037407)
8. Ringborg A, Nieuwlaat R, Lindgren P, et al. Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation. Europace 2008;10:403-11. http://dx.doi.org/10.1093/europace/eun048 (Pubitemid 351767678)
9. Holstenson E, Ringborg A, Lindgren P, et al. Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. Europace 2011;13:23-30. http://dx.doi.org/10.1093/europace/ euq325
10. Reynolds MR, Essebag V, Zimetbaum P, Cohen DJ. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: The FRACTAL Registry. J Cardiovasc Electrophysiol 2007;18:628-633. http://dx.doi.org/10.1111/j.1540-8167.2007.00819.x (Pubitemid 46800517)
11. McBride D, Mattenklotz AM, Willich SN, Bruggenjurgen B. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. Value Health 2009; 12:293-301. http://dx.doi.org/10.1111/j.1524-4733.2008.00416.x
12. National Institute for Health and Care Excellence (NICE). Support for commissioning: anticoagulation therapy. May 2013. Available at: http://publications.nice.org.uk/support-for-commissioning-anticoagulation- therapy-cmg49 [Last accessed 20 September 2013].
13. Rose P, James R, Chapman O, Marshall S. A real world evaluation to describe the characteristics, outcomes and resource use associated with patients being managed by a secondary care based anticoagulation service. ISPOR 14th Annual European Congress, 5-8 Nov 2011, Madrid, Spain [Abstract PCV128].
14. Fitzmaurice DA, Murray ET, McCahon D, et al. Self management of oral anticoagulation: randomised trial. BMJ 2005;331(7524):1057. http://dx.doi.org/ 10.1136/bmj.38618.580903.AE
15. Department of Health. National Schedule of Reference Costs 2009-10 for NHS Trusts. 2011. Available at: https://www.gov.uk/government/publications/nhs- reference-costs-2009-2010 [Last accessed 24 March 2014].
16. NHS Kidney Care. Developing Robust Reference Costs for Kidney Transplantation in Adults, Final Report. 2010:1-40.
17. National Institute for Health and Clinical Excellence (NICE). Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin, CG95. 2010. Available at: http://www.nice.org.uk/CG95 [Last accessed 21 March 2014].
18. Beckett G, Toft A. First-line thyroid function tests - TSH alone is not enough. Clin Endocrinol (Oxf) 2003;58:20-1. http://dx.doi.org/10.1046/j.1365- 2265.2003.01690.x (Pubitemid 36098843)
19. Personal Social Services Research Unit (PSSRU). Unit costs of Health and Social Care 2010. Available at: http://www.pssru.ac.uk/uc/uc2010contents.htm [Last accessed 19 March 2013].
20. Joint Formulary Committee. British National Formulary. Edition 61. London: BMJ Group and Pharmaceutical Press; 2011.
21. Keech M, Punekar Y, Choy A-M. Trends in atrial fibrillation hospitalisation in Scotland: an increasing cost burden. Br J Cardiol 2012;19:173-7. http://dx.doi.org/10.5837/bjc.2012.031